Early Neurologic Complications and Long-term Neurologic Outcomes of Extracorporeal Membrane Oxygenation Performed in Children

• Published in: Klinische Padiatrie Vol. 234; no. 2; p. 96
• Main Authors: Azapagasi, Ebru, Kendirli, Tanıl, Tunçer, Gokcen Oz, Perk, Oktay, Isikhan, Selen Yilmaz, Tıras, Serap Teber, Eyileten, Zeynep, Ince, Erdal, Uysalel, Adnan, Akar, Ahmet Rüçhan
• Format: Journal Article
• Language: English
• Published: Germany 01.03.2022
• Subjects: Child; Cohort Studies; Extracorporeal Membrane Oxygenation - adverse effects; Humans; Infant; Retrospective Studies; Seizures; Treatment Outcome
• ISSN: 1439-3824
• DOI: 10.1055/a-1749-6096

We aimed at evaluating acute neurologic complications (ANC) and clinical outcome at a 2-year follow-up in children after extracorporeal membrane oxygenation (ECMO). We conducted a single-center, retrospective review of our patient cohort aged between 1 month and 18 years at the time of ECMO support (between June 2014 to January 2017). Outcome analysis included ANC and their clinical consequences.The Pediatric Overall Performance Category (POPC) and Pediatric Cerebral Performance Category (PCPC) were used for neurologic assessment performed at discharge from the hospital and at 2nd year follow-up. There were 35 children who required ECMO. The median ECMO time was 9 days (range 2-32 days). Decannulation from ECMO was achieved in 68.6% of patients, and overall, 42.8% survived (15 patients), The incidence of ANC in the surviving patients was 40% (6 children). ANC were intracranial hemorrhage, seizures, cerebral infarction, which occurred in one, two and three of the 15 surviving patients respectively (6.6, 13.3 and 20%). A higher rate of organ failure was related to death (p=0.043), whereas duration on ECMO was a risk factor for the development of ANC (p<0.05). At hospital discharge, the 14 patients evaluated had normal development or -mild disability in 73.2%, and at the 2-year follow-up, 93.4% had these scores. Children who receive ECMO have a risk to develop ANC, which was related to the length of ECMO treatment, while survival was related to less organ failure, Long-term neurological outcome was good in our patient cohort.